Article
Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
The Journal of antimicrobial chemotherapy - 1 Oct 2014
Delang Leen, Segura Guerrero Nidya, Tas Ali, Quérat Gilles, Pastorino Boris, Froeyen Mathy, Dallmeier Kai, Jochmans Dirk, Herdewijn Piet, Bello Felio, Snijder Eric J, de Lamballerie Xavier, Martina Byron, Neyts Johan, van Hemert Martijn J, Leyssen Pieter
Abstract excerpt
OBJECTIVES: T-705, also known as favipiravir, is a small-molecule inhibitor that is currently in clinical development for the treatment of influenza virus infections. This molecule also inhibits the replication of a broad spectrum of other RNA viruses. The objective of this study was to investigate the antiviral effect of favipiravir on chikungunya virus (CHIKV) replication and to contribute to unravelling the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
